Antidiabetic effect of oleanolic acid: A promising use of a traditional pharmacological agent

Phytotherapy Research

Volumn 25, Issue 7, 2011, Pages 1031-1040

  Wang, Xin ^a   Li, Yu Liang ^a   Wu, Hao ^a   Liu, Jiang Zheng ^a   Hu, Jun Xia ^a   Liao, Nai ^a   Peng, Jie ^a   Cao, Pei Pei ^a   Liang, Xin ^a   Hai, Chun Xu ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antidiabetic effect; Diabetes; Hepatic gluconeogenesis; Insulin resistance; Oleanolic acid

Indexed keywords

AMYLASE; GLUCOSE; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE; OLEANOLIC ACID; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG USE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN RESISTANCE; LIVER CELL; LIVER PROTECTION; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; RAT; SIGNAL TRANSDUCTION; TRADITIONAL MEDICINE; WEIGHT REDUCTION;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; HEPATOCYTES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; OLEANOLIC ACID; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 84860388999     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3385     Document Type: Article

References (32)

1. Abdul-Ghani M, Jenkinson C, Richardson D, Tripathy D, De Fronzo R. 2006. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes 55:1430-1435. (Pubitemid 44195383)
2. Ali H, Houghton PJ, Soumyanath A. 2006. [alpha]-Amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus. J Ethnopharmacol 107:449-455. (Pubitemid 44363032)
3. Baynes J, Thorpe S. 1996. The role of oxidative stress in diabetic complications. Curr Opin Endocrinol 3:277.
4. Cheng K, Liu J, Liu X, Li H, Sun H, Xie J. 2009. Synthesis of glucoconjugates of oleanolic acid as inhibitors of glycogen phosphorylase. Carbohydr Res 344:841-850.
5. Cheng K, Liu J, Sun H, Xie J. 2010. Synthesis of oleanolic acid dimers as inhibitors of glycogen phosphorylase. Chem Biodivers 7:690-697.
6. Choukem SM, Sobngwi E M P, Fetita LM et al. 2008. Multitissue insulin resistance despite near-normoglycemic remission in Africans with ketosis-prone diabetes. Diab Care 31:2332-2337.
7. Chu R, Zhao X, Griffin C et al. 2010. Selective concomitant inhibition of mTORC1 and mTORC2 activity in estrogen receptor negative breast cancer cells by BN107 and oleanolic acid. Int J Cancer 127:1209-1219.
8. de Melo CL, Queiroz MG, Fonseca SG et al. 2010. Oleanolic acid, a natural triterpenoid improves blood glucose tolerance in normal mice and ameliorates visceral obesity in mice fed a high-fat diet. Chem Biol Interact 185:59-65.
9. Kasuga M. 2006. Insulin resistance and pancreatic beta cell failure. J Clin Invest 116:1756-1760. (Pubitemid 44033294)
10. Kim JA, Wei Y, Sowers JR. 2008. Role of mitochondrial dysfunction in insulin resistance. Circ Res 102:401-414. (Pubitemid 351651099)
11. Kim NN, Stankovic T, Cushman M U T, Goldstein I, Munarriz R, Traish AM. 2006. Streptozotocin-induced diabetes in the rat is associated with changes in vaginal hemodynamics, morphology and biochemical markers. BMC Physiol 6:4.
12. Leelayuwat N, Tunkumnerdthai O, Donsom M et al. 2008. An alternative exercise and its beneficial effects on glycaemic control and oxidative stress in subjects with type 2 diabetes. Diabetes Res Clin Pract 82:5-8.
13. Lim JH, Lee HJ, Ho Jung M, Song J. 2009. Coupling mitochondrial dysfunction to endoplasmic reticulum stress response: A molecular mechanism leading to hepatic insulin resistance. Cell Signal 21:169-177.
14. Lin W, Wang C, Tsai Y, Liu C, Hwang J, Tseng T. 2000. Inhibitory effect of esculetin on oxidative damage induced by t-butyl hydroperoxide in rat liver. Arch Toxicol 74:467.
15. Lin Z, Zhang Y, Zhang Y et al. 2008. Oleanolic acid derivative NPLC441 potently stimulates glucose transport in 3 T3-L1 adipocytes via a multi-target mechanism. Biochem Pharmacol 76:1251-1262.
16. Manna P, Sinha M, Sil PC. 2009. Protective role of arjunolic acid in response to streptozotocin-induced type-I diabetes via the mitochondrial dependent and independent pathways. Toxicology 257:53-63.
17. Mapanga RF, Tufts MA, Shode FO, Musabayane CT. 2009. Renal effects of plant-derived oleanolic acid in streptozotocininduced diabetic rats. Ren Fail 31:481-491.
18. Muin JK, Rodolfo V, Ann A. 2008. Public health genomics approach to type 2 diabetes. Diabetes 57:2911-2914.
19. Munch G, Keis R, Wessels A et al. 1997. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem 35:669-677.
20. Perez-Camino M, Cert A. 1999. Quantitative determination of hydroxy pentacyclic triterpene acids in vegetable oils. J Agric Food Chem 47:1558.
21. Rakieten N, Rakieten M, Nadkarni M. 1963. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep 29:91.
22. Ritchie R. 2009. Evidence for a causal role of oxidative stress in the myocardial complications of insulin resistance. Heart Lung Circ 18:11-18.
23. Seghrouchni I, Drai J, Bannier E et al. 2002. Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency. Clin Chim Acta 321:89-96. (Pubitemid 34597057)
24. Shah OJ, Wang Z, Hunter T. 2004. Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr Biol 14:1650-1656. (Pubitemid 39239362)
25. Teodoro T, Zhang L, Alexander T, Yue J, Vranic M, Volchuk A. 2008. Oleanolic acid enhances insulin secretion in pancreatic [beta]-cells. FEBS Lett 582:1375-1380.
26. Turner N, Heilbronn LK. 2008. Is mitochondrial dysfunction a cause of insulin resistance? Trends Endocrinol Metab 19:324-330.
27. Wang X, Hai CX, Liang X, Yu SX, Zhang W, Li YL. 2010a. The protective effectsof Acanthopanax senticosus Harms aqueous extracts against oxidative stress: Role of Nrf2 and antioxidant enzymes. J Ethnopharmacol 127:424-432.
28. Wang X, Ye XL, Liu R et al. 2010b. Antioxidant activities of oleanolic acid in vitro: Possible role of Nrf2 and MAP kinases. Chem Biol Interact 184:328-337.
29. Wang ZH, Hsu CC, Huang CN, Yin MC. 2010c. Anti-glycative effects of oleanolic acid and ursolic acid in kidney of diabetic mice. Eur J Pharmacol 628:255-260.
30. Xi M, Hai C, Tang H, Chen M, Fang K, Liang X. 2007. Antioxidant and antiglycation properties of total saponins extracted from traditional Chinese medicine used to treat diabetes mellitus. Phytother Res 22:228-237. (Pubitemid 351363243)
31. Yoon JC, Puigserver P, Chen G et al. 2001. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413:131-138. (Pubitemid 32867868)
32. Zhang YN, Zhang W, Hong D et al. 2008. Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities. Bioorg Med Chem 16:8697-8705.